A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal Cancer

NCT01589419 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Locally Advanced Rectal Cancer

Interventions

DRUG: veliparib
DRUG: capecitabine
RADIATION: radiation

Sponsor

AbbVie (prior sponsor, Abbott)